China Shineway Pharmaceutical Group (FRA:C1S) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C1S China Shineway Pharmaceutical Group Ltd FRA:C1S
92 GF Score
Price €0.86
GF Value €0.73
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:C1S vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Shineway Pharmaceutical Group Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Short Interest distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Short Interest falls into.


FRA:C1S
92GF Score
China Shineway Pharmaceutical Group Ltd FRA:C1S
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Shineway Pharmaceutical Group (FRA:C1S) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of €0.86 is trading 17.8% above its estimated GF Value™ of €0.73. GuruFocus considers China Shineway Pharmaceutical Group to be Modestly Overvalued.

Key valuation signals for FRA:C1S:

  • Short Interest:
  • GF Value™: €0.73 vs. price of €0.86 (17.8% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the FRA:C1S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for FRA:C1S

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€0.73
GF Value